Human Sensory Neuron-like Cells and Glycated Collagen Matrix as a Model for the Screening of Analgesic Compounds

Increased collagen-derived advanced glycation end-products (AGEs) are consistently related to painful diseases, including osteoarthritis, diabetic neuropathy, and neurodegenerative disorders. We have recently developed a model combining a two-dimensional glycated extracellular matrix (ECM-GC) and primary dorsal root ganglion (DRG) that mimicked a pro-nociceptive microenvironment. However, culturing primary cells is still a challenge for large-scale screening studies. Here, we characterized a new model using ECM-GC as a stimulus for human sensory-like neurons differentiated from SH-SY5Y cell lines to screen for analgesic compounds. First, we confirmed that the differentiation process induces the expression of neuron markers (MAP2, RBFOX3 (NeuN), and TUBB3 (β-III tubulin), as well as sensory neuron markers critical for pain sensation (TRPV1, SCN9A (Nav1.7), SCN10A (Nav1.8), and SCN11A (Nav1.9). Next, we showed that ECM-GC increased c-Fos expression in human sensory-like neurons, which is suggestive of neuronal activation. In addition, ECM-GC upregulated the expression of critical genes involved in pain, including SCN9A and TACR1. Of interest, ECM-GC induced substance P release, a neuropeptide widely involved in neuroinflammation and pain. Finally, morphine, the prototype opiate, decreased ECM-GC-induced substance P release. Together, our results suggest that we established a functional model that can be useful as a platform for screening candidates for the management of painful conditions.

Download Full-text

cAMP signaling through protein kinase A and Epac2 induces substance P release in the rat spinal cord

Neuropharmacology ◽

10.1016/j.neuropharm.2021.108533 ◽

2021 ◽

pp. 108533

Author(s):

Wenling Chen ◽

James A. McRoberts ◽

Helena S. Ennes ◽

Juan Carlos Marvizon

Keyword(s):

Spinal Cord ◽

Protein Kinase ◽

Substance P ◽

Protein Kinase A ◽

Camp Signaling ◽

Rat Spinal Cord ◽

P Release ◽

Substance P Release ◽

Kinase A

Download Full-text

Calcium and capsaicin- induced substance P release from peripheral terminals of primary sensory neurons

Regulatory Peptides ◽

10.1016/0167-0115(88)90337-0 ◽

1988 ◽

Vol 22 (1-2) ◽

pp. 117 ◽

Cited By ~ 14

Author(s):

C.A. Maggi ◽

P. Santicioli ◽

P. Geppetti ◽

R. Patacchini ◽

E. Del Bianco ◽

...

Keyword(s):

Substance P ◽

Sensory Neurons ◽

Primary Sensory Neurons ◽

P Release ◽

Substance P Release

Download Full-text

Sufentanil, Morphine, Met-enkephalin, and k-Agonist (U-50,488H) Inhibit Substance P Release from Primary Sensory Neurons

Anesthesiology ◽

10.1097/00000542-198904000-00022 ◽

1989 ◽

Vol 70 (4) ◽

pp. 672-677 ◽

Cited By ~ 48

Author(s):

H. Ming Chang ◽

Charles B. Berde ◽

George G. Holz ◽

Grieg F. Steward ◽

Richard M. Kream

Keyword(s):

Substance P ◽

Sensory Neurons ◽

Primary Sensory Neurons ◽

P Release ◽

Inhibit Substance ◽

Substance P Release

Download Full-text

Hypertonicity, but not hypothermia, elicits substance P release from rat C-fiber neurons in primary culture.

Journal of Clinical Investigation ◽

10.1172/jci117928 ◽

1995 ◽

Vol 95 (5) ◽

pp. 2359-2366 ◽

Cited By ~ 38

Author(s):

A Garland ◽

J E Jordan ◽

J Necheles ◽

L E Alger ◽

M M Scully ◽

...

Keyword(s):

Substance P ◽

Primary Culture ◽

P Release ◽

C Fiber ◽

Substance P Release

Download Full-text

Effects of General Anesthetics on Substance P Release and c-Fos Expression in the Spinal Dorsal Horn

Anesthesiology ◽

10.1097/aln.0b013e31829996b6 ◽

2013 ◽

Vol 119 (2) ◽

pp. 433-442 ◽

Cited By ~ 5

Author(s):

Toshifumi Takasusuki ◽

Shigeki Yamaguchi ◽

Shinsuke Hamaguchi ◽

Tony L. Yaksh

Keyword(s):

Nitrous Oxide ◽

Substance P ◽

Dorsal Horn ◽

Receptor Internalization ◽

General Anesthetics ◽

Neurokinin 1 Receptor ◽

P Release ◽

Fos Expression ◽

Neurokinin 1 ◽

Substance P Release

Abstract Background: The authors examined in vivo the effects of general anesthetics on evoked substance P release (primary afferent excitability) and c-Fos expression (neuronal activation) in superficial dorsal horn. Methods: Rats received saline, propofol (100 mg/kg), pentobarbital (50 mg/kg), isoflurane (2 minimum alveolar concentration), nitrous oxide (66%), or fentanyl (30 μg/kg). During anesthesia, rats received intraplantar 5% formalin (50 μl) to left hind paw. Ten minutes later, rats underwent transcardial perfusion with 4% paraformaldehyde. Substance P release from small primary afferents was assessed by incidence of neurokinin 1 receptor internalization in the superficial dorsal horn. In separate studies, rats were sacrificed after 2 h and c-Fos expression measured. Results: Intraplantar formalin-induced robust neurokinin 1 receptor internalization in ipsilateral dorsal horn (ipsilateral: 54 ± 6% [mean ± SEM], contralateral: 12 ± 2%; P < 0.05; n = 4). Fentanyl, but not propofol, pentobarbital, isoflurane, nor nitrous oxide alone inhibited neurokinin 1 receptor internalization. However, 2 minimum alveolar concentration isoflurane + nitrous oxide reduced neurokinin 1 receptor internalization (27 ± 3%; P < 0.05; n = 5). All agents reduced c-Fos expression (control: 34 ± 4, fentanyl: 8 ± 2, isoflurane: 12 ± 3, nitrous oxide: 11 ± 2, isoflurane + nitrous oxide: 12 ± 1, pentobarbital: 11 ± 2, propofol: 13 ± 3; P < 0.05; n = 3). Conclusion: General anesthetics at anesthetic concentrations block spinal neuron activation through a mechanism that is independent of an effect on small primary afferent peptide release. The effect of fentanyl alone and the synergistic effect of isoflurane and nitrous oxide on substance P release suggest a correlative rationale for the therapeutic use of these anesthetic protocols by blocking nociceptive afferent transmitter release and preventing the initiation of cascade, which is immediately postsynaptic to the primary afferent.

Download Full-text